Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Agenus Inc (NASDAQ: AGEN) was $6.12 for the day, up 0.49% from the previous closing price of $6.09. In other words, the price has increased by $0.49 from its previous closing price. On the day, 1.09 million shares were traded. AGEN stock price reached its highest trading level at $6.14 during the session, while it also had its lowest trading level at $5.67.
Ratios:
Our analysis of AGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.11 and its Current Ratio is at 0.11.
On July 19, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $35 to $8.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGEN now has a Market Capitalization of 167790816 and an Enterprise Value of 260796128. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.69. Its current Enterprise Value per Revenue stands at 2.62 whereas that against EBITDA is -2.844.
Stock Price History:
The Beta on a monthly basis for AGEN is 1.62, which has changed by -0.0016313195 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, AGEN has reached a high of $7.34, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is 27.00%, while the 200-Day Moving Average is calculated to be 72.80%.
Shares Statistics:
AGEN traded an average of 1.36M shares per day over the past three months and 1683680 shares per day over the past ten days. A total of 26.56M shares are outstanding, with a floating share count of 26.20M. Insiders hold about 4.43% of the company’s shares, while institutions hold 31.89% stake in the company. Shares short for AGEN as of 1751241600 were 2545292 with a Short Ratio of 1.88, compared to 1748563200 on 3865104. Therefore, it implies a Short% of Shares Outstanding of 2545292 and a Short% of Float of 9.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
As of right now, 3.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.22, with high estimates of $0.25 and low estimates of -$0.65.
Analysts are recommending an EPS of between $6.14 and -$3.03 for the fiscal current year, implying an average EPS of $1.9. EPS for the following year is -$1.28, with 4.0 analysts recommending between $1.16 and -$4.88.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $99.1M to a low estimate of $25M. As of the current estimate, Agenus Inc’s year-ago sales were $23.51MFor the next quarter, 3 analysts are estimating revenue of $24.98M. There is a high estimate of $25.84M for the next quarter, whereas the lowest estimate is $24.1M.
A total of 5 analysts have provided revenue estimates for AGEN’s current fiscal year. The highest revenue estimate was $392M, while the lowest revenue estimate was $99.07M, resulting in an average revenue estimate of $172.5M. In the same quarter a year ago, actual revenue was $103.46MBased on 5 analysts’ estimates, the company’s revenue will be $119.49M in the next fiscal year. The high estimate is $146.3M and the low estimate is $100M.
